MET and neoplasm: Among the genes identified in this signature, we noted, consistent with our earlier analyses, GATA3 and MET enrichment in subgroup 10 and 7 tumors, respectively, both of which are known to be preferentially expressed in luminal and basal tumor, respectively (Additional file 4, Figure S13).